10.900
+6,86%
2026-10-02
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +35.2% | +829.8% | 2 / 3 | -24.8% | -15.39 pp | -10.75 pp | -21.0% | 2.63 | — | 34,7 | −24,8% | −6,8 | −67,0% | — | 54.93 | — |
| Pts | 8 | 12 | 8 | 0 | 0 | 0 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 10.900 (close price on 2026-10-02)EPS (TTM): −826,8
Financial charts
1.Revenue & growth
VND bn34,7Q2/26
1.Revenue & growth
VND bn34,7Q2/26
2.Profit & growth
VND bn-6,23Q2/26
3.Profit mix (Penman)
VND bn-5,22Q2/26
4.Margins & cost structure
%4.5%Q2/26
5.Returns & cash cycle
% · days1.9%Q2/26
6.Earnings quality & cash
VND bn-32,5Q2/26
7.Asset structure
VND bn217Q2/26
8.Funding & debt health
VND bn · times217Q2/26
9.Revenue backlog
VND bn0,54Q2/26
10.Valuation
times · %-3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-1.831Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-447%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
158%
Source: vnstockData through Q2/26